Biophytis Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Stanislas Veillet
Chief executive officer
€349.0k
Total compensation
CEO salary percentage | 71.6% |
CEO tenure | 9yrs |
CEO ownership | 2.9% |
Management average tenure | 3.6yrs |
Board average tenure | 4.7yrs |
Recent management updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | €349k | €250k | -€17m |
Sep 30 2023 | n/a | n/a | -€18m |
Jun 30 2023 | n/a | n/a | -€20m |
Mar 31 2023 | n/a | n/a | -€22m |
Dec 31 2022 | €428k | €250k | -€24m |
Sep 30 2022 | n/a | n/a | -€27m |
Jun 30 2022 | n/a | n/a | -€30m |
Mar 31 2022 | n/a | n/a | -€31m |
Dec 31 2021 | €460k | €250k | -€31m |
Sep 30 2021 | n/a | n/a | -€28m |
Jun 30 2021 | n/a | n/a | -€25m |
Mar 31 2021 | n/a | n/a | -€25m |
Dec 31 2020 | €374k | €250k | -€26m |
Sep 30 2020 | n/a | n/a | -€24m |
Jun 30 2020 | n/a | n/a | -€22m |
Mar 31 2020 | n/a | n/a | -€22m |
Dec 31 2019 | €310k | €250k | -€19m |
Sep 30 2019 | n/a | n/a | -€19m |
Jun 30 2019 | n/a | n/a | -€18m |
Mar 31 2019 | n/a | n/a | -€15m |
Dec 31 2018 | €295k | €225k | -€14m |
Sep 30 2018 | n/a | n/a | -€13m |
Jun 30 2018 | n/a | n/a | -€12m |
Mar 31 2018 | n/a | n/a | -€12m |
Dec 31 2017 | €447k | €150k | -€11m |
Compensation vs Market: Stanislas's total compensation ($USD372.35K) is about average for companies of similar size in the French market ($USD324.51K).
Compensation vs Earnings: Stanislas's compensation has been consistent with company performance over the past year.
CEO
Stanislas Veillet (58 yo)
9yrs
Tenure
€349,000
Compensation
Mr. Stanislas Veillet, Ph D., serves as Chairman of the Board and Chief Executive Officer of Biophytis SA since May 22, 2015. Mr. Veillet is the Co-founder of Biophytis (created in 2006) and served as its...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 9yrs | €349.00k | 2.86% € 68.8k | |
Chief Financial Officer | less than a year | no data | no data | |
Chief Clinical Operating Officer | 4.6yrs | no data | 0.022% € 517.2 | |
Chief Scientific Officer | 4.6yrs | no data | 0.012% € 298.9 | |
Scientific Advisor & Member of Scientific Advisory Board | 4.7yrs | no data | no data | |
Chief Medical Officer | 2.7yrs | no data | 0.0066% € 159.6 | |
Chief Business Officer | less than a year | no data | no data | |
Chief Pharmaceutical Operations Officer & Quality Assurance Director | 1.3yrs | no data | 0.0066% € 159.6 | |
Financial Controller | no data | no data | no data |
3.6yrs
Average Tenure
54yo
Average Age
Experienced Management: ALBPS's management team is considered experienced (3.6 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board & CEO | 9yrs | €349.00k | 2.86% € 68.8k | |
Scientific Advisor & Member of Scientific Advisory Board | 4.7yrs | no data | no data | |
Independent Director | 2.8yrs | €25.00k | 0% € 0 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 6.6yrs | no data | no data | |
Member of Scientific Advisory Board | 8yrs | no data | no data | |
Chairman of Scientific Advisory Board & Director | 8.1yrs | €25.00k | 0% € 0 | |
Independent Director | 9yrs | €25.00k | 0.00011% € 2.6 | |
Member of Scientific Advisory Board | less than a year | no data | no data | |
Member of Scientific Advisory Board | less than a year | no data | no data | |
Member of Scientific Advisory Board | less than a year | no data | no data | |
Member of Scientific Advisory Board | less than a year | no data | no data |
4.7yrs
Average Tenure
68yo
Average Age
Experienced Board: ALBPS's board of directors are considered experienced (4.7 years average tenure).